Carlos Alban, EVP, Commercial Operations at AbbVie Inc. (ABBV), sold 193,124 shares at $117.85 ($22.2M) on 2018-02-28, disclosed to the SEC on 2018-03-02.
Seasonal sale ($22.2M) by EVP, Commercial Operations — this insider has traded ABBV in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.85 | 2,579 | $304K | 1.4% |
| 2 | $117.85 | 2,579 | $304K | 1.4% |
| 3 | $118.26 | 25,976 | $3.1M | 13.8% |
| 4 | $113.75 | 19,169 | $2.2M | 9.8% |
| 5 | $113.75 | 19,169 | $2.2M | 9.8% |
| 6 | $114.43 | 14,829 |
| $1.7M |
| 7.6% |
| 7 | $114.43 | 14,829 | $1.7M | 7.6% |
| 8 | $114.63 | 46,997 | $5.4M | 24.3% |
| 9 | $114.63 | 46,997 | $5.4M | 24.3% |
| Total | $115.00 avg | 193,124 | $22.2M | 100% |
| Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |
| ABBV | SELL | 2016-05-12 | $6.0M | — | Filing → |